Anticoagulants, Antiplatelets & Thrombolytics Flashcards
Haemostasis
to stop bleeding in haemorrhage
Involves: local vasoconstriction, platelet aggregation and coagulation
Thrombosis
pathological, coagulation in the absence of bleeding
Involves: Virchow’s triad
Virchow’s triad
increase coagulation, vessel damage and abnormal blood flow
Arterial thrombus
white, platelet aggregation, embolus tends to cause stroke
Venous thrombus
red, white head, red-jelly tail, fibrin rich, embolus tends to lodge in lung: PE
Platelets in coagulation cascade
endothelial damage –> platelet aggregation–> mediator (pre-existing (ADP) and newly formed (TXA2)) release, further platelet aggregation
Fibrin in coagulation cascade
endothelial damage –> clotting factor release –> X activated (Xa) –> prothrombin –> thrombin (converts fibrinogen to fibrin (forms a fibrin mesh)
Fibrin clot formation
Platelet aggregation + blood coagulation
Thrombin
fibrinogen to fibrin
Platelet function
brings clotting factors closer together for activation
Activation of clotting factors
gamma-carboxylation
gamma carboxylation enzyme
carboxylase
Essential requirement of carboxylase?
vitamin K - therefore is required for coagulation
Warfarin target?
blocks vitamin K reductase - stopping vitamin K from binding to it (preventing gamma carboxylation and coagulation)
Anticoagulant function?
prevention/ treatment of venous thrombosis/ embolism
Caution with anticoagulants?
risk of haemorrhage
Which clotting factors does warfarin block?
II, VII, IX & X
How is warfarin standardly taken?
orally
Fast or slow action?
slow (2-3 days)
Half life?
long (40 hrs)
Warfarin warnings?
difficulty of balancing anticoagulance with haemorrhage risk - low therapeutic index
Factors that increase haemorrhage risk when on warfarin?
liver disease (less clotting factors) fast metabolism (fast clotting factor clearance) drug interaction: agents that inhibit hepatic metabolism of warfarin drugs that inhibit platelet function (aspirin and NSAIDS) drugs that inhibit reduction or availability of vitamin K
Factors that inhibit warfarin action (increase thrombosis risk)?
physiological state: pregnancy (higher clotting factor synthesis), hypothyroidism (less degradation of clotting factors), vitamin K consumption, drugs that increase the metabolism of warfarin
warfarin overdose treatment?
vitamin K or concentrate of clotting factors
Antithrombin III main function?
important inhibitor of coagulation
Action of antithrombin III?
neutralises serine protease factors (II, VII, IX, X) in coagulation cascade
Heparin mechanism?
binds to antithrombin III, increasing its affinity for serine protease factors, increasing the rate of clotting factor inactivation
What does heparin need to bind to to inhibit IIa (thrombin)?
Antithrombin III and IIa
What does heparin need to bind to to inhibit Xa
Antithrombin III
Examples of LMWHs?
enoxaparin, dalteparin
What do LMWHs inhibit?
factor Xa but not IIa (thrombin)
Heparin administration?
IV - immediate action
Subcutaneous - 1hr delay
How are LMWHs excreted?
Renal excretion
Adverse affects of heparin and LMWHs?
haemorrhage
osteoperosis (long term treatment)
hypoaldosteronism
hypersensetivity reactions
How to reverse heparin effects?
protamine sulphate
Orally active inhibitor action?
directly inhibits thrombin or Xa, to prevent venous thrombosis
Example of orally active inhibitor?
dabigatran etexillate
Advantages of orally active inhibitors?
administration convenience
predictable degree of anticoagulation
Disadvantages of orally active inhibitors?
No agent to reverse haemorrhage in overdose
Anti platelets act on which type of thrombosis?
arterial thrombosis
Anti coagulants act on which type of thrombosis?
Venous thrombosis
How to platelets attach to damaged vessels?
via surface glycoproteins and von williebrand factor (acts as a bridge)
Aggregation occurs due to which molecules?
ADP 5-hydrotrytamine (5-HT) Thromboxane A2 (TXA2) via COX enzyme
These all cause cell surface receptors of platelets to express glycoprotein IIb/ IIIa
How do glycoproteins cross link platelets in platelet aggregation?
via fibrinogen
Acidic phospholipid exposure on platelet surface promotes the formation of?
Thrombin IIa - which stimulates further platelet aggregation
how is the mass of platelets stabilised?
Through the conversion of fibrinogen to fibrin
What is the role of ADP in platelet aggregation?
attracts more platelets
Role of TXA2 in platelet aggregation?
promotes platelet aggregation, degranulation and vasoconstriction
What is released when platelets degranulate due to TXA2?
more ADP and TXA2
Platelet aggregation mainly occurs in which form of clot formation?
haemostasis
What is the main anti platelet drug in use?
aspirin
how does aspirin work as an anti platelet?
blocks COX and prevents TXA2 synthesis
inhibits prostaglandin I2 production (TXA2 precursor)
side effects of aspirin?
GI bleeding and ulceration
Clopidogrel function?
links to P2Y12 receptor - irreversible inhibition
When is clopidogrel normally used?
when a patient is intolerant of aspirin
Aspirin administration?
normally oral
Clopidogrel administration?
oral
Tirofiban used when?
MI prophylaxis in high risk CV patients with unstable angina
Tirofiban short or long term drug?
short term
Tirofiban administration?
IV
plasminogen and fibrinolytic drugs act against what?
the coagulation cascade
What is the role of plasmin?
dissolves fibrin converting it into fibrin filaments
Plasminogen and fibrinolytic drugs act to do what?
reopen occluded arteries in acute MI or stroke
Administration of plasminogen and fibrinolytic drugs?
IV asap
What is preferred to the use of plasminogen and fibrinolytic drugs?
PCI if prompt
What does PCI entail?
non-surgical widening of coronary artery with stent placement after dilatation
What drug should be administered alongside PCI?
aspirin
Adverse effects of streptokinase?
Antibodies block action after 4 days
can cause allergies
When is streptokinase contraindicated?
In recent strep infection patients
What is alteplase (and duteplase)?
recombinant tissue plasminogen activator (rt-PA)
Benefits of alte/ duteplase?
no allergies
Administration of Alte/ duteplase?
short half life so IV infusion
MAJOR fibrinolytic adverse side effect?
haemorrhage
Control of haemorrhage due to fibrinolytic?
tranexamic acid - inhibits plasminogen activation